Anti hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders
β Scribed by L. Sheng; A. Soumillion; K. Peerlinck; C. Verslype; R. Schelstraete; F. Gyselinck; M-P. Emonds; G. Hess; J. Vermylen; J. Desmyter; S.H. Yap
- Book ID
- 118568722
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 189 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We compared characteristics of patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA to those of patients with GBV-C/HGV E2-antibody. GBV-C/HGV RNA and GBV-C/HGV antibody were assayed in 83 persons with hemophilia using a reverse transcription-polymerase chain reaction and an enzyme-linked immu
## Abstract A novel DNA virus, TT virus (TTV), has been proposed as a possible etiologic agent for non AβE hepatitis. The aim of the present study was to determine the prevalence of TTV infection using PCR in healthy blood donors and in patients with clotting disorders who have been investigated pr
Extensive serological testing and HCV RNA determination by RT-PCR was performed in serum, PBMCs, and liver tissue i n thirteen anti-HCV reactive patients with persistently normal liver tests. Absolute concordance in the status of HCV RNA between serum, PBMCs, and liver was noted. Five patients were